Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
VEGF antagonist formulations suitable for intravitreal administration

No-Receipt date 2013-01526 - 22/05/2013
No-Filing date 20130401018 - 22/05/2013
No-Granting date 3080786 - 27/05/2013
No-EPO application date 11157965.2 - 14/06/2007
No-EPO granting date 2364691 - 24/04/2013
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 5/2013 - 14/06/2013
Expiration date 15/06/2027
Kind of title Validation of European Patent
Legal status VALID
Priorities US814484 P16/06/2006/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 38/00
A61K 9/00
A61K 9/19

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
478247 REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROADTARRYTOWN, NY 10591 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
1142648 FURFINE, ERIC
1142649 DIX, DANIEL
1142650 GRAHAM, KENNETH, S.
1142651 FRYE, KELLY

Representatives
CodeFirstnameSurnameAddressTownZip
25MARIAATHANASIADOUKOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
848EFANGELIAGIAZITZOGLOU - THOMAIDOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments
DateOperationDescreption
7/11/2023 12:00:00 AMΔιάφορες Μεταβολές (70004) ΑΡ.ΠΡΩΤ. 4430/10-02-2023 (ΛΙΣΤΑ) (ΑΡ.ΥΠΟΘ. 4654017/10-02-2023) ΔΝΥ. 440 ΚΩΔ.ΠΛΗΡ. 3464 ΑΡΣΗ & ΑΝΤΙΚΑΤΑΣΤΑΣΗ ΑΝΤΙΚΛΗΤΟΥ

Payments history 18 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015